India-based. Globally connected.   Online · On-site · Hybrid

Industry-specific applications

AI for Pharma

Knowledge organization and controlled document drafting.

A direct answer

How should a pharma team approach AI adoption?

Start with a task that has clear source information and an accountable reviewer. NMR Infotech can combine AI training, workflow discovery and solution development around that task. The right starting point depends on tool access, information sensitivity and how the output will be used.

Useful starting points

Which pharma workflows can you explore?

Outline internal training materials; structure approved reference summaries; draft review checklists.

These are proposed learning and discovery examples, not claims about completed client deployments.

Train. Transform. Build.

How can NMR Infotech support your team?

Transform

02

AI Consulting

Identify AI opportunities, design adoption strategies and transform workflows.

Explore AI consulting

Build

03

AI Development

Build AI-powered software, websites, agents and business applications.

Explore AI development

Responsible use

What review boundaries matter?

Use approved sources and human quality review. Generated material does not replace validated processes or regulatory approval.

A practical first step

What happens in a discovery conversation?

  1. Identify the team and the recurring task.
  2. Review approved tools, permitted examples and necessary access.
  3. Choose a training exercise or pilot scope.
  4. Agree output quality checks and the people responsible for review.

A bounded starting point

What could a first pilot look like?

Illustrative scenario · Pharma

Internal learning-material outline

Input
Approved, non-confidential reference content and an internal learning objective.
Expected draft
An outline with source references and a list of points requiring subject-matter review.
Review owner
Quality or subject-matter owner
Failure cases to test
Unsupported product claims, missing qualifiers, outdated references and language that implies approval not present in the source.

This is a proposed learning scenario, not a client case study or a completed deployment.

Implementation boundaries

What needs to be agreed before implementation?

A drafted summary is not a validated controlled document. Existing quality and regulatory review processes continue to apply.

  • Define the permitted input, intended output and decisions the workflow cannot make.
  • Check source ownership, access rights and the selected tool environment.
  • Test routine examples alongside missing, conflicting and out-of-scope inputs.
  • Agree who approves the result and what happens when the workflow cannot answer.

Your questions

Pharma program planning

Can AI drafts go directly into controlled documentation?

No. Training output is a draft for review. Any use in controlled documentation requires the organization’s established approval and validation process.

Your next chapter with AI

Ready to Make AI Work for Your Business?

Tell us what you want to train, improve, automate or build.